,,ii #aai? ,,congress #b;d ,session ,s4 #dhge ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,june #bc1 #bjbf,mr4 ,b5net 7= himself1 ,mr4 ,"y1 ,mrs4 ,gillibr&1 ,mr4 ,r\nds1 & ,mr4 ,hick5loop]7 introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ,a ,,bill ,to am5d ! ,public ,heal? ,s]vice ,act to e/abli% a program to develop innovative antimicrobial drugs t>get+ ! mo/ *all5g+ pa?og5s & mo/ ?reat5+ infections1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,pione]+ ,antimicrobial ,subscriptions ,to ,end ,upsurg+ ,resi/ance ,act ( #bjbf or ! ,,pa/eur ,act ( #bjbf4 #b4 ,purpose ,! purpose ( ?is ,act is to ensure ! availability ( antimicrobials to-- 7#a7 /imulate a new age ( rese>*1 developm5t1 & m>ket access to lifesav+ m$ic9es2 7#b7 ensure ! appropriate use ( lifesav+ m$ic9es2 7#c7 ma9ta9 ! highe/ m$ical c>e /&>ds = ,am]ican pati5ts2 7#d7 promote national heal? sy/em prep>$ness2 & 7#e7 def5d ! ,unit$ ,/ates & its milit>y4 #c4 ,develop+ antimicrobial innovations ,title ,,iii ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bda et seq47 is am5d$ by add+ at ! end ! foll[+3 ,x ,u4,s4 ,,novel ,,antimicrobial ,,supply ,,contracts #cii,,pp4 ,contract application1 aw>d1 & implem5tation 7a7 ,9 g5]al ,! ,secret>y may ent] into contracts ) sponsors ( eligible antimicrobials = ! purpose ( ensur+ ! availability ( su* eligible antimicrobials4 7b7 ,eligible antimicrobial ,to be eligible = a contract "u ?is section1 an antimicrobial drug %all-- 7#a7 treat a pa?og5-- 7,a7 includ$ z an urg5t or s]i\s ?reat 9 ! mo/ rec5t ,antibiotic ,resi/ance ,?reats 9 ! ,unit$ ,/ates report publi%$ by ! ,c5t]s = ,disease ,control & ,prev5tion2 or 7,b7 t ! ,secret>y has det]m9$ appropriate 9 consultation ) ! ,advisory ,gr\p e/abli%$ "u section #cii,,pp-#a2 & 7#b7 address an unmet m$ical ne$4 7c7 ,applications 7#a7 ,submission ,to be eligible to ent] into a contract "u ?is section1 a sponsor ( an eligible antimicrobial %all submit to ! ,secret>y an application n lat] ?an #b ye>s aft] ! date on :i* ! eligible antimicrobial is-- 7,a7 approv$ "u section #eje7;c7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7includ+ 9 accordance ) section #ejf7;h7 ( su* ,act72 or 7,b7 lic5s$ "u section #cea7;a7 ( ?is ,act4 7#b7 ,cont5ts ,an application submitt$ "u p>agraph 7#a7 ) respect to an eligible antimicrobial-- 7,a7 %all include-- 7i7 appropriate in=mation to det]m9e ! score ( ! eligible antimicrobial 9 accordance ) ! me?odology e/abli%$ "u subsection 7d72 & 7ii7 su* o!r in=mation z ! ,secret>y det]m9es appropriate2 & 7,b7 is n requir$ to include in=mation relat+ to pric+ or rese>* & developm5t co/s ( ! eligible antimicrobial4 7#c7 ,review ,n lat] ?an #ij days aft] ! date on :i* ! ,secret>y receives an application "u ?is subsection ) respect to an eligible antimicrobial 7includ+ a revis$ application "u p>agraph 7#d771 ! ,secret>y %all-- 7,a7 review ! application2 7,b7 if ! eligible antimicrobial's score is bel[ ! m9imum scor+ ?re%old describ$ 9 subsection 7d77#a77;,b71 d5y ! application2 & 7,c7 if ! eligible antimicrobial's score meets or exce$s su* m9imum scor+ ?re%old1 approve ! application & calculate annual paym5ts = ! contract "u subsection 7f74 7#d7 ,revis$ applications ,beg9n+ #a ye> aft] ! d5ial ( an application ) respect to an eligible antimicrobial "u p>agraph 7#c71 & n m frequ5tly ?an once e #b ye>s !reaft]1 ! sponsor ( ! eligible antimicrobial may submit to ! ,secret>y a revis$ application = ! eligible antimicrobial ) additional in=mation t may mat]ially affect ! eligible antimicrobial's score "u subsection 7d74 7d7 ,scor+ 7#a7 ,9 g5]al ,n lat] ?an #bgj days aft] ! date ( enactm5t ( ?is "p1 ! ,secret>y1 9 consultation ) ! ,advisory ,gr\p e/abli%$ "u section #cii,,pp-#a1 ! ,assi/ant ,secret>y = ,prep>$ness & ,response1 ! ,director ( ! ,biom$ical ,advanc$ ,rese>* & ,developm5t ,au?ority1 & ! ,commission] ( ,food & ,drugs1 %all promulgate regulations1 aft] ! consid]ation ( comm5ts receiv$ 9 response to a public reque/ = in=mation & a public he>+1 e/abli%+-- 7,a7 a quantitative scor+ me?odology = eligible antimicrobials = :i* applications are submitt$ "u ?is section2 & 7,b7 a m9imum scor+ ?re%old t ! score ( an eligible antimicrobial "u p>agraph 7#b7 mu/ meet or exce$ 9 ord] = ! sponsor ( su* eligible antimicrobial to ent] into a contract "u ?is section4 7#b7 ,me?odology ,an eligible antimicrobial %all receive a score1 calculat$ by po9ts aw>d$ bas$ on crit]ia develop$ 9 consultation ) ! ,advisory ,gr\p e/abli%$ "u section #cii,,pp-#a )9 ! foll[+ ?ree categories1 ) a weight+ assign$ to ea* crit]ion e/abli%$ "u su* categories & a great] numb] ( po9ts result+ 9 a high] score3 7,a7 ,category i ,! eligible antimicrobial's major contributions to pati5t c>e1 includ+-- 7i7 improv+ cl9ical outcomes = pati5ts ) multi-drug-resi/ant infections2 7ii7 improv$ dose frequ5cy2 7iii7 r$uc$ toxicity2 7iv7 r$uctions 9 adv]se ev5ts2 & 7v7 b5efits f ! eligible antimicrobial's r\te ( adm9i/ration1 especially ?r\gh oral adm9i/ration or m ?an "o adm9i/ration me?od4 7,b7 ,category ii ,! innovative *>act]i/ics ( ! eligible antimicrobial1 includ+-- 7i7 be+ a fir/-approv$ antimicrobial drug t has ! pot5tial to address1 or has ! evid5ce ( address+1 unmet m$ical ne$s = ! treatm5t ( a s]i\s or life-?reat5+ infection1 or1 to a less] ext5t1 second & ?ird drugs t treat su* infection2 7ii7 conta9+ no active moiety 7z def9$ 9 section #cad4c ( title #ba1 ,code ( ,f$]al ,regulations 7or any successor regulations77 t has be5 approv$ 9 any o!r application "u section #eje7;b7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act & conta9+ no active +r$i5t lic5s$ 9 any o!r biological product lic5se application "u section #cea7;a7 ( ?is ,act2 7iii7 be+ a memb] ( a new class ( drugs ) a novel t>get or novel mode ( action t are di/9ctly diff]5t f ! t>get or mode ( any antimicrobial drug approv$ "u su* section #eje7;b7 or lic5s$ "u su* section #cea7;a72 & 7iv7 address+ a multi-drug resi/ant infection ?r\gh a novel *emical scaffold or mode ( action4 7,c7 ,category iii ,! b5efit ( ! eligible antimicrobial to heal? sy/ems & public heal?1 includ+-- 7i7 n be+ affect$ by cross-resi/ance to "o or m antimicrobials approv$ "u su* section #eje7;b7 or lic5s$ "u su* section #cea7;a72 7ii7 manufactur+ capabilities )9 ! ,unit$ ,/ates2 7iii7 improv$ product /ability & /orage2 7iv7 increas$ activity aga9/ resi/ance me*anisms2 & 7v7 r$uction ( ! economic or population burd5 ( antimicrobial resi/ance 9 ! ,unit$ ,/ates4 7e7 ,contract requirem5ts ,z a condition ( ent]+ into a contract "u ?is section ) respect to an eligible antimicrobial1 ! sponsor ( ! eligible antimicrobial %all-- 7#a7 beg9n+ on ! date t is #cj days aft] ! sponsor receives its fir/ paym5t "u ! contract & = ! rema9d] ( ! contract t]m1 ensure-- 7,a7 ! comm]cial availability ( ! eligible antimicrobial 9 ! ,unit$ ,/ates2 & 7,b7 suffici5t supply ( ! eligible antimicrobial = antimicrobial susceptibility te/ device manufactur]s2 7#b7 id5tify1 track1 & publicly report drug resi/ance data & tr5ds us+ available data relat$ to ! eligible antimicrobial1 includ+ ! use ( data collect$ by ! ,secret>y "u section #cii,,pp-#b7;c72 7#c7 develop & implem5t education & communications /rategies = heal? c>e pr(essionals & pati5ts conc]n+ ! appropriate use ( ! eligible antimicrobial1 su* z-- 7,a7 in=mation f label+ approv$ by ! ,food & ,drug ,adm9i/ration2 & 7,b7 communications = individuals ) limit$ ,engli% pr(ici5cy & individuals ) disabilities2 7#d7 submit to ! ,secret>y a plan reg>d+ ! appropriate use ( ! eligible antimicrobial1 includ+ be/ practices = antimicrobial /ew>d%ip & a g5]al description ( h[ ! product w be m>ket$4 ,! appropriate use plan may include a plan to collect data on ! impact ( diagno/ics1 antimicrobial /ew>d%ip programs1 & o!r appropriate use ef=ts on pati5t outcomes & heal?-c>e co/s2 7#e7 ^u ! reque/ ( ! ,secret>y1 submit to ! ,secret>y a plan = regi/]+ ! eligible antimicrobial 9 c\ntries o!r ?an ! ,unit$ ,/ates :]e an unmet m$ical ne$ exi/s2 7#f7 und]take ef=ts to ensure a reliable drug supply *a91 includ+1 9 ! ev5t ( ! ,food & ,drug ,adm9i/ration det]m9+ t a %ortage exi/s = ! eligible antimicrobial1 n lat] ?an #cj days aft] su* det]m9ation submitt+ to ! ,secret>y a plan to address su* %ortage2 7#g7 beg9n+ on ! date t is #cj days aft] ! sponsor receives its fir/ paym5t "u ! contract & = ! rema9d] ( ! contract t]m1 manufacture ! eligible antimicrobial drug at a volume t reasonably ensures ! availability ( suffici5t quantities ( ! drug to meet ! ne$s ( individuals ) ! disease or condition = :i* ! eligible antimicrobial is approv$ 9 ! ,unit$ ,/ates2 7#h7 abide by manufactur+ & environm5tal be/ practices = ! control ( dis*>ge ( antimicrobial active ph>maceutical +r$i5ts & o!r antimicrobial ag5ts or products1 includ+ ! antibiotic manufactur+ /&>d develop$ by ! ,,amr ,indu/ry ,alliance 7z describ$ 9 ! report titl$ ,m9imiz+ risk ( develop+ antibiotic resi/ance & aquatic ecotoxicity 9 ! environm5t result+ f ! manufactur+ ( human antibiotics publi%$ 9 ,may #bjbe7 or seek+ a su/a9ability c]tification f ,,bsi ,/&>ds ,limit$2 & 7#i7 abide by su* o!r t]ms z ! ,secret>y may require "u ! contract4 7f7 ,annual paym5ts 7#a7 ,9 g5]al ,pursuant to a contract ent]$ into "u ?is section1 ! ,secret>y %all make annual paym5ts to ! sponsor ( an eligible antimicrobial = ! duration ( ! contract t]m4 ,su* paym5ts %all beg9 n lat] ?an #ahj days aft] ! date on :i* ! ,secret>y approves ! contract4 7#b7 ,calculation sy/em ,! ,secret>y1 9 consultation ) ! ,adm9i/rator ( ! ,c5t]s = ,m$ic>e ,m$icaid ,s]vices1 %all promulgate regulations e/abli%+ a sy/em = ! calculation ( ! annual paym5ts describ$ 9 p>agraph 7#a74 ,su* sy/em %all adh]e to ! foll[+3 7,a7 ,m9imum & maximum am\nt ,an annual paym5t may n be less ?an #ge1jjj1jjj or m ?an #cjj1jjj1jjj1 adju/$ on an annual basis 9 accordance ) ! consum] price index = all urban consum]s 7all items2 ,unit$ ,/ates city av]age74 7,b7 ,adju/m5t = net rev5ue ,! annual paym5t %all be adju/$ d[nw>d by ! am\nt ( net rev5ue f sales 9 ! ,unit$ ,/ates ( ! eligible antimicrobial dur+ ! previ\s #ab-mon? p]iod1 includ+ any legally m&at$ or volunt>y disc\nts & rebates provid$ by ! sponsor ( ! eligible antimicrobial1 su* z volume disc\nts1 prompt pay disc\nts1 ca% disc\nts1 free goods t are cont+5t on any pur*ase requirem5t1 *>gebacks1 & rebates4 7#c7 ,disclosure ( in=mation ,! ,secret>y may require ! sponsor ( an eligible antimicrobial to disclose to ! ,secret>y su* in=mation z ! ,secret>y requires to calculate an annual paym5t "u ?is subsection4 ,not)/&+ any o!r provision ( law1 su* in=mation %all be kept confid5tial & may n be-- 7,a7 disclos$ by ! ,secret>y to any entity1 includ+ o!r gov]nm5tal or private p>ties1 9 a =m t reveals ! id5tity ( a specific manufactur] or ! prices *>g$ = drugs by su* manufactur]2 or 7,b7 us$ by ! ,secret>y = any purpose o!r ?an calculat+ ! annual paym5ts "u ?is subsection4 7#d7 ,t]m9ation ( paym5ts ,! ,secret>y may cease annual paym5ts pursuant to a contract ent]$ into "u ?is section if ! ,secret>y det]m9es t ! sponsor ( ! eligible antimicrobial subject to su* contract-- 7,a7 p]man5tly )draws ! eligible antimicrobial f ! m>ket 9 ! ,unit$ ,/ates2 7,b7 mat]ially fails to meet "o or m ( ! requirem5ts describ$ 9 subsection 7e7 aft] notice by ! ,secret>y & an opportunity to correct2 or 7,c7 does n conduct ) due dilig5ce a po/m>ket /udy requir$ to be complet$ by ! ,food & ,drug ,adm9i/ration dur+ ! t]m ( ! contract4 7#e7 ,rule ( con/ruction ,no?+ 9 ?is subsection %all be con/ru$ z au?oriz+ ! ,secret>y-- 7,a7 to disclose any in=mation t is a trade secret or confid5tial in=mation subject to section #eeb7;b77#d7 ( title #e1 ,unit$ ,/ates ,code1 or section #aije ( title #ah1 ,unit$ ,/ates ,code2 or 7,b7 to use evid5ce f comp>ative cl9ical effectiv5ess rese>* 9 a mann] t treats ext5d+ ! life ( an eld]ly1 disabl$1 or t]m9ally ill individual z ( l[] value ?an ext5d+ ! life ( an individual :o is y\ng]1 nondisabl$1 or n t]m9ally ill = ! purposes ( calculat+ annual paym5ts "u ?is subsection1 includ+ 9 su* a way t w\ld limit pati5t access4 7g7 ,contract t]m 7#a7 ,l5g? ( t]m ,! t]m ( a contract ent]$ into "u ?is section %all end on ! e>li] (-- 7,a7 ! date t is #aj ye>s aft] ! date on :i* ! contract is approv$2 & 7,b7 ! date on :i* ! ,secret>y det]m9es at lea/ "o drug or biological product is-- 7i7 approv$ or lic5s$ 7z applicable7-- 7,i7 "u section #eje7;j7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act1 us+ ! contract antimicrobial z ! li/$ drug2 or 7,,ii7 "u section #cea7k7 ( ! ,public ,heal? ,s]vice ,act1 us+ ! contract antimicrobial z ! ref]5ce product2 & 7ii7 m>ket$ pursuant to su* approval or lic5sure4 7#b7 ,effect ,a contract %all rema9 9 effect = ! t]m describ$ 9 p>agraph 7#a7 ev5 if ! pa?og5 treat$ by ! eligible antimicrobial is lat] remov$ f ! ,antibiotic ,resi/ance ,?reats 9 ! ,unit$ ,/ates report describ$ 9 subsection 7b77#a77;,a74 7h7 ,o!r gov]nm5t p>ticipation ,! ,secret>y %all make ef=ts to increase ! p>ticipation ( o!r gov]nm5tal bodies 9 (f]+ f9ancial inc5tives to create comm]cial access to new & novel antimicrobials t are simil> to ! contracts "u ?is section4 7i7 ,au?ority ve/$ 9 ! secret>y ,! au?ority ve/$ 9 ! ,secret>y by ?is section to ent] into contracts may be p]=m$ )\t reg>d to su* provisions ( law or regulations relat+ to ! mak+1 p]=mance1 am5dm5t1 or modification ( contracts ( ! ,unit$ ,/ates1 z ! ,secret>y may det]m9e to be inconsi/5t ) ! fur!rance ( ! purposes ( ?is "p4 #cii,,pp-#a4 ,critical ne$ antimicrobial advisory gr\p 7a7 ,9 g5]al ,n lat] ?an #fj days aft] ! date ( enactm5t ( ?is "p1 ! ,secret>y %all e/abli% a ,critical ,ne$ ,antimicrobial ,advisory ,gr\p 7ref]r$ to 9 ?is "p z ! ,advisory ,gr\p7 & appo9t its memb]s4 7b7 ,memb]s ,! ,advisory ,gr\p %all be compos$ ( #ae memb]s1 to be appo9t$ by ! ,secret>y z foll[s3 7#a7 #d individuals :o are physicians bo>d-c]tifi$ 9 infecti\s diseases4 7#b7 #d individuals :o are exp]ts ) demon/rat$ exp]tise 9 antimicrobial resi/ance1 heal? economics1 or rese>* & developm5t or comm]cialization ( antimicrobial drugs4 7#c7 #d individuals to s]ve z pati5t advocates1 :o are well v]s$ 9 antimicrobial treatm5t or resi/ance1 ei!r z pati5ts !mselves or z c>etak]s4 7#d7 #c additional individuals :o meet ! qualifications specifi$ 9 p>agraph 7#a71 7#b71 or 7#c74 7c7 ,*air ,9 addition to ! memb]s appo9t$ "u subsection 7b71 ! ,secret>y %all appo9t #a individual to s]ve z a non-vot+ ,*air ( ! ,advisory ,gr\p4 ,su* individual %all meet ! qualifications specifi$ 9 p>agraph 7#a71 7#b71 or 7#c7 ( subsection 7b74 7d7 ,conflicts ( int]e/ ,9 appo9t+ memb]s "u subsection 7b7 & a ,*air "u subsection 7c71 ! ,secret>y %all ensure t no memb] 7includ+ ! ,*air7 receives dur+ ! individual's t]m ( s]vice ) ! ,advisory ,gr\p comp5sation 9 any mann] f a comm]cial or =-pr(it entity t develops or int5ds to develop antimicrobial drugs4 ,9 implem5t+ ! requirem5ts ( ?is "p1 ! ,secret>y %all prohibit ,advisory ,gr\p memb]s 7includ+ ! ,*air7 f p>ticipat+ 9 any p>ticul> ,advisory ,gr\p matt] t w h a direct & pr$ictable effect on _! f9ancial int]e/s4 7e7 ,applicability ( ,,faca 7#a7 ,9 g5]al ,except z o!rwise provid$ 9 ?is section1 *apt] #aj ( title #e1 ,unit$ ,/ates ,code 7commonly ref]r$ to z ! ,f$]al ,advisory ,committee ,act7 %all apply to ! ,advisory ,gr\p4 7#b7 ,t]m9ation ,section #ajac ( su* title 7relat+ to ! t]m9ation ( advisory committees7 %all n apply to ! ,advisory ,gr\p4 #cii,,pp-#b4 ,enc\rag+ appropriate use ( antimicrobials & combat+ resi/ance 7a7 ,heal? facility grant program 7#a7 ,9 g5]al ,n lat] ?an #a ye> aft] ! date ( enactm5t ( ?is "p1 ! ,secret>y1 act+ ?r\gh ! ,director ( ! ,c5t]s = ,disease ,control & ,prev5tion 79 ?is subsection ref]r$ to z ! ,secret>y71 %all e/abli% a grant program to support hospital1 skill$ nurs+ facility1 & o!r heal? c>e facility ef=ts-- 7,a7 to judici\sly use antimicrobial drugs1 su* z by e/abli%+ or implem5t+ appropriate use programs1 includ+ infecti\s disease teleheal? programs1 us+ appropriate diagno/ic tools1 p>tn]+ ) academic hospitals1 increas+ heal? c>e-associat$ infection report+ & prev5tion ef=ts1 & monitor+ antimicrobial resi/ance2 & 7,b7 to p>ticipate 9 ! ,national ,heal?c>e ,safety ,network ,antimicrobial ,use & ,resi/ance ,module or ! ,em]g+ ,infections ,program ,heal?c>e-,associat$ ,infections ,community ,int]face activity ( ! ,c5t]s = ,disease ,control & ,prev5tion1 z specifi$ by ! ,secret>y1 relat+ to antimicrobial drugs4 7#b7 ,prioritization ,9 aw>d+ grants "u p>agraph 7#a71 ! ,secret>y %all prioritize heal? c>e facilities )\t an exi/+ program to judici\sly use antimicrobial drugs1 subsection 7d7 hospitals 7z def9$ 9 section #ahhf7;d77#a77;,b7 ( ! ,social ,security ,act7 t are locat$ 9 rural areas 7z def9$ 9 section #ahhf7;d77#b77;,d7 ( su* ,act71 critical access hospitals 7z def9$ 9 section #ahfa7mm77#a7 ( su* ,act71 hospitals s]v+ ,tribal populations1 & safety-net hospitals4 7#c7 ,/&>ds = use ( grant funds ,9 implem5t+ or exp&+ an antibiotic /ew>d%ip program1 an entity receiv+ a grant "u p>agraph 7#a7 %all adh]e to nationally recogniz$ guidel9es & be/ practices1 includ+ adequate /aff+1 = improv+ antibiotic use4 7b7 ,antimicrobial /ew>d%ip pilot program = outpati5t facilities 7#a7 ,antimicrobial /ew>d%ip pilot program = outpati5t facilities ,n lat] ?an #b ye>s aft] ! date ( enactm5t ( ?is "p1 ! ,secret>y1 9 consultation ) ! ,director ( ! ,c5t]s = ,disease ,control & ,prev5tion & ! ,adm9i/rator ( ! ,c5t]s = ,m$ic>e ,m$icaid ,s]vices 79 ?is subsection ref]r$ to z ! ,secret>y71 %all e/abli% a pilot program to make grants to entities to implem5t or exp& antibiotic /ew>d%ip programs 9 outpati5t facilities4 7#b7 ,implem5tation ,9 develop+ ! pilot program1 ! ,secret>y %all consult ) pr(essional societies ) exp]tise 9 antibiotic /ew>d%ip4 7#c7 ,eligible entities ,to be eligible to receive a grant "u p>agraph 7#a71 an entity %all be-- 7,a7 a physician2 7,b7 a hospital outpati5t dep>tm5t2 7,c7 an urg5t c>e sett+ describ$ 9 p>agraph 7#e77;,a72 or 7,d7 a retail cl9ic describ$ 9 p>agraph 7#e77;,b74 7#d7 ,/&>ds = use ( grant funds ,9 implem5t+ or exp&+ an antibiotic /ew>d%ip program ?r\gh a grant "u ?is subsection1 an entity %all adh]e to nationally recogniz$ guidel9es & be/ practices1 includ+ adequate /aff+1 = improv+ antibiotic use4 7#e7 ,prioritization ,9 aw>d+ grants "u p>agraph 7#a71 ! ,secret>y %all prioritize-- 7,a7 urg5t c>e sett+s1 su* z facilities t use ,place ( ,s]vice ,code #bj = urg5t c>e develop$ by ! ,c5t]s = ,m$ic>e ,m$icaid ,s]vices 7or any successor code72 & 7,b7 retail cl9ics1 mean+ facilities t are co-locat$ ) a ph>macy or o!r retail comm]cial e/abli%m5t1 su* z ^? t use ,place ( ,s]vice ,code #ag = walk-9 retail heal? cl9ics develop$ by ! ,c5t]s = ,m$ic>e ,m$icaid ,s]vices 7or any successor code74 7#f7 ,report ,n lat] ?an #e ye>s aft] ! date ( enactm5t ( ?is "p1 ! ,secret>y %all submit to ,congress a report on ! impacts ( ! pilot program1 includ+ recomm5dations = exp&+ antimicrobial /ew>d%ip to additional outpati5t sett+s4 7c7 ,surveillance & report+ ( antimicrobial use & resi/ance 7#a7 ,9 g5]al ,! ,secret>y1 act+ ?r\gh ! ,director ( ! ,c5t]s = ,disease ,control & ,prev5tion1 %all use ! ,national ,heal?c>e ,safety ,network & o!r appropriate surveillance sy/ems to collect data & assess tr5ds 9 antimicrobial resi/ance & antibiotic & antifungal use1 su* z-- 7,a7 appropriate conditions & measures causally relat$ to antimicrobial resi/ance1 includ+ types ( infections1 ! s\rce or body sites ( infections1 ! demographic in=mation ( pati5ts ) infections1 infection onset 9 a community or hospital sett+1 increas$ l5g?s ( hospital /ay1 increas$ co/s1 & rates ( mortality2 & 7,b7 *anges 9 bact]ial & fungal resi/ance to antimicrobial drugs1 includ+ *anges 9 p]c5t resi/ance1 preval5ce ( antimicrobial-resi/ant infections1 rates ( mortality1 & o!r su* *anges4 7#b7 ,antimicrobial use data ,! ,secret>y1 act+ ?r\gh ! ,director ( ! ,c5t]s = ,disease ,control & ,prev5tion1 %all obta9 reliable & comp>able human antibiotic & antifungal drug consumption data 7includ+1 z available & appropriate1 volume antimicrobial di/ribution data & antibiotic & antifungal use data1 includ+ prescription data7 by ,/ate or metropolitan areas4 ,to accompli% ?is1 ! ,secret>y may "w )1 z appropriate1 ,f$]al dep>tm5ts & ag5cies 7includ+ ! ,dep>tm5t ( ,vet]ans ,affairs1 ! ,dep>tm5t ( ,def5se1 ! ,dep>tm5t ( ,homel& ,security1 ! ,bureau ( ,prisons1 ! ,indian ,heal? ,s]vice1 & ! ,c5t]s = ,m$ic>e ,m$icaid ,s]vices71 private v5dors1 heal? c>e organizations1 ph>macy b5efit manag]s1 & o!r entities4 7#c7 ,antimicrobial resi/ance tr5d data ,! ,secret>y1 act+ ?r\gh ! ,director ( ! ,c5t]s = ,disease ,control & ,prev5tion1 %all int5sify & exp& ef=ts to collect antimicrobial resi/ance data & enc\rage adoption ( ! ,antimicrobial ,use & ,resi/ance ,module or o!r appropriate module )9 ! ,national ,heal?c>e ,safety ,network & o!r appropriate surveillance sy/ems among all heal? c>e facilities across ! cont9uum ( c>e1 includ+1 z appropriate1 acute c>e hospitals1 dialysis facilities1 nurs+ homes1 ambulatory surgical c5t]s1 & o!r ambulatory heal? c>e sett+s 9 :i* antimicrobial drugs are r\t9ely prescrib$4 ,! ,secret>y %all seek to collect su* data f electronic m$ication adm9i/ration reports & laboratory sy/ems to produce ! reports describ$ 9 p>agraph 7#e74 7#d7 ,diagno/ics data ,! ,secret>y %all collect data on te/s us$ to diagnose & in=m ! appropriate treatm5t ( infections 9 heal? c>e sett+s4 ,?is includes data on ! implem5tation ( diagno/ic /ew>d%ip to ensure ! appropriate use ( a diagno/ic te/ be=e a treatm5t is prescrib$1 & ! use ( diagno/ics 9 monitor+ & track+ infecti\s diseases4 ,! ,secret>y %all collect data on ! use ( diagno/ic te/s ?r\gh ! ,national ,heal?c>e ,safety ,network 79 ?is p>agraph ref]r$ to z ! ,,nhsn7 ,antimicrobial ,use & ,resi/ance ,module or o!r appropriate ,,nhsn module4 ,^! ef=ts %all be implem5t$ 9 collaboration ) ext]nal /akehold]s1 includ+ infecti\s disease pr(essional societies1 pati5t advocacy organizations1 heal? c>e sy/ems & pr(essionals1 & ! diagno/ics indu/ry4 7#e7 ,public availability ( data ,beg9n+ on ! date t is #b ye>s aft] ! date ( enactm5t ( ?is "p1 ! ,secret>y %all1 = ! purposes ( improv+ ! monitor+ ( important tr5ds 9 antimicrobial use & resi/ance1 &1 z appropriate1 pati5t outcomes 9 relation to antimicrobial resi/ance-- 7,a7 make ! data describ$ 9 p>agraphs 7#a7 ?r\gh 7#d7 publicly available ?r\gh reports & web updates issu$ on a regul> basis t is n less ?an annually2 & 7,b7 exam9e opportunities to make su* data available 9 ne> real "t4 #cii,,pp-#c4 ,def9itions ,9 ?is "p3 7#a7 ,antimicrobial drug ,! t]m antimicrobial drug-- 7,a7 means-- 7i7 a drug t directly inhibits replication ( or kills bact]ia or fungi1 or acts on ! sub/ances produc$ by su* bact]ia or fungi1 relevant to ! propos$ indication at conc5trations likely to be atta9able 9 humans to a*ieve ! int5d$ !rapeutic effect2 & 7ii7 a biological product t acts directly on bact]ia or fungi or on ! sub/ances produc$ by su* bact]ia or fungi2 & 7,b7 does n include-- 7i7 a drug t a*ieves ! effect describ$ 9 subp>agraph 7,a77i7 only at a conc5tration t _c reasonably be /udi$ 9 humans because ( its anticipat$ toxicity2 or 7ii7 a vacc9e4 7#b7 ,contract ,! t]m contract means a transaction o!r ?an a procurem5t contract1 grant1 or a coop]ative agreem5t4 7#c7 ,contract antimicrobial ,! t]m contract antimicrobial means an antimicrobial drug or biological product = :i* a contract "u ?is "p is 9 effect4 7#d7 ,eligible antimicrobial ,! t]m eligible antimicrobial means an antimicrobial drug or biological product t satisfies ! eligibility crit]ia describ$ 9 section #cii,,pp7b74 #cii,,pp-#d4 ,appropriations 7a7 ,9 g5]al ,to c>ry out ?is "p1 !re is au?oriz$ to be appropriat$1 & appropriat$1 to ! ,secret>y1 out ( am\nts 9 ! ,treasury n o!rwise appropriat$1 #f1jjj1jjj1jjj = fiscal ye> #bjbf1 to rema9 available until exp5d$4 7b7 ,allocation ,! ,secret>y may use n m ?an #f4e p]c5t ( ! am\nts appropriat$ "u subsection 7a7 to c>ry out section #cii,,pp-#b4 7c7 ,em]g5cy designation 7#a7 ,9 g5]al ,! am\nts provid$ by ?is section are designat$ z an em]g5cy requirem5t pursuant to section #d7;g7 ( ! ,/atutory ,pay-,z-,y-,g ,act ( #bjaj4 7#b7 ,designation 9 s5ate ,9 ! ,s5ate1 ?is section is designat$ z an em]g5cy requirem5t pursuant to section #daab7;a7 ( ,h4 ,con4 ,res4 #ga 7#aae? ,congress71 ! concurr5t resolution on ! budget = fiscal ye> #bjah4 4